3 matches for your search in the start-up spotlight
rss
Founded in 2022, AlgenScribe SAS is actively crafting a genome editing framework tailored for Human Health encompassing therapeutics, bioproduction, research tools and diagnostics. AlgenScribe's objective is to unlock the complete potential of genome editing, focused on eliminating obstacles that ...
At Mammoth, we discover novel CRISPR systems that enable new possibilities for expanding biology. Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential ...
PROVIREX Genome Editing Therapies GmbH is a privately-held biotech company developing first-in-class advanced therapy medicinal products (ATMPs). PROVIREX’s technology is based on error-free genome editing for eradication of life-threatening persistent virus infection. PROVIREX employs ...
